奥扎格雷与脑得生序贯治疗急性脑梗死的临床观察  被引量:3

Clinical Observation of Sequential Therapy of Ozagrel and Naodesheng in the Treatment of Acute Cerebral Infarction

在线阅读下载全文

作  者:王玉和[1] 余昌胤[2] 张骏[2] 雷显泽[2] 余娜[2] 周妮[2] 

机构地区:[1]遵义医学院附属医院药剂科,贵州遵义563003 [2]遵义医学院附属医院神经内科,贵州遵义563003

出  处:《中国药房》2014年第8期699-701,共3页China Pharmacy

基  金:贵州省卫生厅科学技术基金项目科研课题(No.D-234)

摘  要:目的:观察奥扎格雷与脑得生序贯治疗急性脑梗死的疗效与安全性。方法:采用前瞻性的随机对照试验设计方法,共入选278例急性脑梗死患者,将符合方案分析集的264例患者随机均分为A、B组。两组患者均给予相同的基础治疗。A组患者采用奥扎格雷80 mg静脉滴注,bid,7 d后改用口服脑得生,每次6粒,tid,至第14天;B组患者采用奥扎格雷80 mg静脉滴注,bid,连用14 d。根据患者的神经功能缺损评分和日常生活能力评分进行临床疗效评价,并比较两组患者的不良反应发生情况。结果:A组患者的基本治愈率为31.8%,总有效率为96.2%,不良反应发生率为5.8%;B组患者的基本治愈率为31.1%,总有效率为96.9%,不良反应发生率为7.1%。两组患者在疗效及不良反应发生率等方面比较,差异均无统计学意义(P>0.05)。结论:对于急性脑梗死的患者,采用奥扎格雷与脑得生序贯治疗同连续静脉滴注奥扎格雷治疗效果近似,安全性均良好。OBJECTIVE: To observe the safety and clinical efficacy of sequential therapy of ozagrel and naodesheng in the treatment of acute cerebral infarction. METHODS: By prospective randomized controlled design, 278 patients with acute cerebral infarction were selected. 264 patients were fitted for program, which was randomly divided into 2 groups A and group B. Both groups received same routine treatment. Group A was given ozagrel 80 mg, ivgtt, bid; 7 days later, naodesheng was taken orally instead, 6 pills each time, tid for 7 days. Group B was given ozagrel 80 mg, ivgtt, bid, for 14 days. The neurologic impairment score and activity of daily living were compared after therapy to evaluate the clinical efficacy, and the safety of them were also compared between 2 groups. RESULTS: The basic cure rate of group A was 31.8%, and total effective rate was 96.2%. The incidence of adverse drug reaction was 5.8%. The basic cure rate of group B was 31.1%, and total effective rate was 96.9%. The incidence of adverse drug reaction was 7.1%. There was no statistical significance in clinic efficacy and the incidence of adverse drug reaction (P〉0.05). CONCLUSIONS: The clinical efficacy of sequential therapy of ozagrel and naodesheng is similar to that of continuous intervenous drop of ozagrel in the treatment of acute cerebral infarction. Both show good safety.

关 键 词:急性脑梗死 奥扎格雷 脑得生 序贯治疗 前瞻性 随机对照试验 

分 类 号:R743[医药卫生—神经病学与精神病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象